Sands Capital Ventures

Rgenix is a a discovery platform, revolutionizing the treatment of cancer by generating the first-in-class therapeutics that target key nodes in cancer progression. Its proprietary discovery platform is based on innovations in cancer biology that enable the identification and validation of novel post-transcriptionally regulated targets. Rgenix’s productive approach has yielded multiple novel targets to date across several cancer types for which the company is developing drugs, and its scientific approach has led to the discovery of novel therapeutic targets and first-in-class drugs for several cancer subtypes, including melanoma, colorectal cancer, and triple-negative breast cancer, among others. Its aim is to discover and develop safe, effective, and commercially viable therapies that will transform the lives of cancer patients by treating metastatic disease.

Neptune Financial Inc. is a private equity firm specializing in buyouts, strategic acquisitions, refinancing, recapitalizations and growth capital in lower middle market. The firm provides senior secured term loans with recurring revenue lines. The frim is industry agnostic but it typically invests in business services, financial services, consumer, healthcare, TMT and industrials sectors. It invests in US based companies Non-Sponsored & Sponsored. The firm invests up to $30 million in companies with revenues starting $5 million and above and has EBTIDA of $2 million plus or plan to achieve profitability. It prefers to take majority stake in companies. The firm holds the investment for 3-6 year term. Neptune Financial Inc. was founded in 2017 and is headquartered in San Francisco, California.

Upgrade is a neobank that offers credit to mainstream consumers through cards and personal loans, together with free credit monitoring and education tools that help consumers understand and manage their finances. Upgrade Card provides an innovative credit card that brings the low cost and responsible credit of installment lending to millions of retail locations in the U.S., while Upgrade Account is a mobile banking product offered to mainstream consumers.

Coagulo Medical Technologies, Inc. develops testing systems that detects, identifies, and quantifies the effect of all anticoagulants in whole blood and communicates actionable results to healthcare providers. The company is based in Auburndale, Massachusetts.

Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.

SeLux Diagnostics, Inc. develops a next generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious disease. It develops a synthetic amplifier technology equipment that breaks the speed versus complexity tradeoff in AST testing and dramatically improves patient care. SeLux Diagnostics, Inc. was founded in 2014 and is based in Charlestown, Massachusetts.

Vesper Technologies Inc. develops and manufactures piezoelectric MEMS microphones. It offers its products for various microphone array applications in mobile handsets, tablets, and other products. The company was formerly known as Sonify. The company was founded in 2009 and is based in Boston, Massachusetts.

Complete Genomics' high quality, affordable DNA sequencing enables commercial-scale research of the genetic mechanisms underlying drug responses and complex diseases. Complete Genomics combines innovative technology with a disruptive market approach that will revolutionize DNA sequencing.

BYJU’S is a valuable ed-tech company at USD 10.5 billion and the creator of India’s most loved school learning app which offers highly adaptive, engaging, and effective learning programs for students in classes 1 -12 and competitive exams like JEE, NEET, CAT, and IAS. BYJU'S launched its flagship product, BYJU’S - The Learning App, for classes 4-12 in 2015. Today, the app has over 42 million registered students. With an average time of 71 minutes being spent by a student on the app every day from 1700+ cities, the app is creating a whole new way of learning through visual lessons. The Disney. BYJU'S Early Learn App was launched in June 2019, a special offering from BYJU'S for students in classes 1-3 featuring Disney’s timeliness characters. In early 2019, BYJU'S also acquired Osmo, a Palo Alto-based maker of educational games to transform the whole offline to an online learning experience.

Mekonos Inc. engages in the design, development, and production of gene and cell therapies. The company develops integrated system-on-a-chip to develop predictive models for discovery and development. It develops MEMS, a technology that allows controlling individual nanoneedles to inject single cells, in a parallel architecture. Also, the company operates a cell-engineering platform. The company was founded in 2017 and is based in San Francisco, California

Primer Technologies, Inc. develops software that uses machine learning techniques to help parse and collate a large number of documents across several languages. The company's systems read documents, discover insights, and automatically generate reports comparable to those of a human analyst. It helps governments and corporations monitor and understand the world’s information. Primer Technologies, Inc. was incorporated in 2014 and is based in San Francisco, California.

Karuna Pharmaceuticals, Inc. engages in development of drugs for the treatment of schizophrenia. The company was incorporated in 2009 and is based in Boston, Massachusetts.

Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.

SafeRide focuses on providing patients with transportation services to attend their health appointments in time. SafeRide provides healthcare providers with solutions to send text alerts about appointments and track the rides of their patients. SafeRide was founded by Whit Schrader and Robbins Schrader in April 2015.

DiCE Molecules Corp. develops a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Its technology allows the extension of directed evolution to provide organic compounds as the output. The company also develops a methodology for translating DNA encoded information directly into organic compounds in essence roboticizing the laborious processes of medicinal chemistry. Its technology is used in the fields of pharmaceuticals, agriculture, and materials sciences. DiCE Molecules Corp. was incorporated in 2013 and is based in Menlo Park, California.

Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.

Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system. Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications.

ArcherDX is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays.

SeLux Diagnostics, Inc. develops a next generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious disease. It develops a synthetic amplifier technology equipment that breaks the speed versus complexity tradeoff in AST testing and dramatically improves patient care. SeLux Diagnostics, Inc. was founded in 2014 and is based in Charlestown, Massachusetts.

Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.

Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Uhnder is a start-up developing products for sensing, cognition, and communication for the Internet of Things (IoT) market. It is headquartered in California with engineering and operations based in Austin and St. Louis. Uhnder develops a digital automotive radar-on-chip designed to automate systems for safety and better feedback response. Uhnder disrupts the autonomous vehicle business with what it says is a more accurate and reliable alternative to light detection and ranging, known as lidar, which is one of the most common technologies used to make vehicles more aware of their surroundings. Uhnder's chip helps to avoid collisions, alerts to potential problems, helps with quick localization, as electronic fences for navigation and localization and for communication.

Hungry Marketplace, Inc. operates a mobile food marketplace that connects foodies with local chefs. The company offers HUNGRY, a marketplace that allows user to search and order made-to-order meals prepared by local chefs. It delivers fresh-cooked meals to foodies across District of Columbia, Maryland, and Virginia. The company was founded in 2016 and is based in Arlington, Virginia.

BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.

Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Catalyst helps organize, normalize, and link the data from all different systems. And they make it searchable by all users, even the non-technical, by using rich metadata capabilities.

FraudScope, Inc. develops artificial intelligence (AI) based platform for healthcare fraud, waste, and abuse applications. It offers FraudScope, a software platform to detect, score, and rank suspect medical billing practices; and augment existing methodologies using sophisticated algorithm tuning to detect fraud schemes in raw claims data. The company’s platform also scans medical insurance claims data and creates real-time profiles for each provider, provider type, beneficiary, diagnosis, service profile, and care pathway; aggregates substantiated evidence for the fraud it detects; and ensures that healthcare dollars go to real patient care. FraudScope, Inc. was founded in 2016 and is based in Atlanta, Georgia.

Hungry Marketplace, Inc. operates a mobile food marketplace that connects foodies with local chefs. The company offers HUNGRY, a marketplace that allows user to search and order made-to-order meals prepared by local chefs. It delivers fresh-cooked meals to foodies across District of Columbia, Maryland, and Virginia. The company was founded in 2016 and is based in Arlington, Virginia.

Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Catalyst helps organize, normalize, and link the data from all different systems. And they make it searchable by all users, even the non-technical, by using rich metadata capabilities.

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Security Infrastructure as a Service (SIaaS). LimaCharlie abstracts away the hard parts of information security and delivers them on-demand (or à la carte) at scale in a manner similar to any major cloud provider drastically reducing costs and effort. We supply all the tools to run an MSSP or SOC as well as providing API’s that allow users to build and monetize their own products.

JumpCloud enables IT to securely manage user identities and connect them to resources regardless of provider, protocol, vendor, or location. JumpCloud is the first Directory-as-a-Service (DaaS), Active Directory, and LDAP reimagined. It centralizes and simplifies identity management and gives users one set of credentials to securely access their systems, apps, networks, and file servers – regardless of platform, protocol, provider, or location.

Betable is the world’s first platform that enables any developer to legally offer real-money play in their games and apps on any platform or device. Betable is licensed by the United Kingdom Gambling Commission and Alderney Gambling Control Commission to offer support and infrastructure to developers to legally integrate real-money gambling into their mobile and social games and applications. Betable provides world-leading security, fraud protection, player location, identity and age verification and account monitoring to keep players’ funds safe and to ensure responsible gaming. Betable was founded in 2008 in London, United Kingdom. It also is headquartered in San Francisco, California.

Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Application performance management services and mobile analytics

Nubank issues, administrate, processes, and transfers payments related to post-paid credit cards and equity investment in other entities. It serves clients in Brazil. The company launched its proprietary loyalty rewards program ("Nubank Rewards"), as well as a digital account ("NuConta") that is already used by more than 17 million people. In Cristina Junqueira, David Velez, and Edward Wible founded EO2 Solucoes de Pagamento on May 6, 2013 that became Nubank in on June 25, 2013. It has its headquarters in São Paulo in Brazil.

Paydiant, Inc. provides a cloud-based white label mobile wallet platform. The company’s platform enables merchants, banks, and partners to integrate mobile payments, offers, loyalty, and ATM cash access into their own branded mobile app. It offers its solutions through resellers and distributors. The company was incorporated in 2010 and is based in Auburndale, Massachusetts. As of April 2, 2015, Paydiant, Inc. operates as a subsidiary of PayPal Holdings, Inc.

Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.

Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

DocuSign, Inc. provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals. The company was 2003 and is headquartered in San Francisco, California.

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.

RayzeBio, Inc. is a biotechnology company that develops tumor-targeted small molecule medicines that harness the power of radioisotopes. The company provides macrocyclic peptide mimetic binders to deliver therapeutic radioisotopes, such as Actinium-225, an alpha-emitter for solid tumors. RayzeBio, Inc. was founded in 2020 and is based in San Diego, California.

DiCE Molecules Corp. develops a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Its technology allows the extension of directed evolution to provide organic compounds as the output. The company also develops a methodology for translating DNA encoded information directly into organic compounds in essence roboticizing the laborious processes of medicinal chemistry. Its technology is used in the fields of pharmaceuticals, agriculture, and materials sciences. DiCE Molecules Corp. was incorporated in 2013 and is based in Menlo Park, California.

Prilenia Therapeutics B.V., a clinical stage biotech company, researches and develops products for movement disorders and neurodegenerative diseases affecting adults and children. It offers Pridopidine, an orally bioavailable small molecule investigational drug for huntington disease, amyotrophic lateral sclerosis, Parkinson’s disease levodopa induced dyskinesia, neurodegenerative eye disease, Parkinson’s disease, rett syndrome, fragile X, and Alzheimer’s disease. The company was founded in 2018 and is based in the Netherlands.

Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Catalyst helps organize, normalize, and link the data from all different systems. And they make it searchable by all users, even the non-technical, by using rich metadata capabilities.

Boom Sports is a technology company whose mission is to entertain and connect sports fans through games. After building the most popular real-money pick 'em daily fantasy product (2-time EGR app of the year), we're designing and operating world-class, free-to-play, games for media, league, and pro sports team partners. Our flagship product is NBC Sports Predictor, which offers fans in all 50 states the chance to win real money based on their (free) predictions. The product has been a huge success -- hundreds of thousands of active users, a 4.8 app store rating on 2K+ reviews -- and has provided a model for others that want to maximize the value of their audience in advance of legalized sports betting. If you want to build (legal) sports gaming products for the next generation of fans, come join us! We're hiring!

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric disorders and pain. Its lead product candidate is KarXT, an oral modulator that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, Alzheimer’s, and pain, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts.

Genometry, Inc. operates as a platform-technology company that gene-expression profiling solutions for pharmaceutical discovery applications. It produces gene-expression profiles from crude cell lysates in well plate format. The company’s biomedical-research community also engages in drug-discovery activities. It offers data-generation and primary analysis solutions to the pharmaceutical and biotechnology industries, non-profit organizations, and academic researchers. Genometry, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.

Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Opinio is a fast growing start-up that builds next generation last mile delivery service for food, grocery, bakery, peer-to-Peer and more. Founded by IIT Kanpur Computer Science graduates, company started its operations on 15th of June, 2015. They recently got funded by India's biggest VC firm, Accel Partners (Portfolio Companies: Facebook, Flipkart, Myntra etc.) Operating on a B2B model, they partner with local merchants to help them deliver goods to the customer through our fast expanding fleet of Ground Pilot's.

Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.

Tomorrow's Insights Today: Spend less time on reporting and more time on executing. We built Tellius to make big data simple for the modern workforce. Cut through swathes of information and find the answers you’re looking for whether you’re an IT pro, marketing guru or C-level exec. Tellius extends traditional self-service BI concepts through the use search-enabled visualizations and a proprietary recommendation engine that automates the basic interpretation and analysis of data. Using machine learning, Tellius analyzes data to find hidden correlations, trends and anomalies which are then presented as a set of suggested visualizations and predictive models. Unlike traditional BI tools, Tellius is built on a distributed architecture (Apache Spark) which provides the scale and performance required for Big Data environments.

When Funding Circle was founded, they could see that businesses weren’t being given the finance to grow, while investors were making poor returns. They had a simple idea — let them support each other. By lending directly to businesses through Funding Circle, investors can now earn attractive returns to better provide for their future. Businesses get fast, easy access to funding to grow, create jobs, support local communities and drive the economy forward. They believe it’s better for everyone.

Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Upgrade is a neobank that offers credit to mainstream consumers through cards and personal loans, together with free credit monitoring and education tools that help consumers understand and manage their finances. Upgrade Card provides an innovative credit card that brings the low cost and responsible credit of installment lending to millions of retail locations in the U.S., while Upgrade Account is a mobile banking product offered to mainstream consumers.

Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Acumen Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics and diagnostics for treating Alzheimer’s disease and related neurodegenerative conditions. The company focuses on developing ADDL-Select antibodies that target soluble Aß oligomers, which are main causes in the disease process. It also uses a sensitivity assay to measure soluble Aß oligomer levels in the cerebrospinal fluid in patients to be enrolled in clinical trials. Acumen Pharmaceuticals, Inc. was founded in 1996 and is based in Livermore, California.

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. The company is driven by its mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal. They are committed to transforming the quality of life for patients who have been underserved by scientific innovation.

Shine Analytics Limited develops a hosted platform for managing and controlling external legal costs. Its platform helps in-house counsel teams to navigate the new legal market reality. The company was founded in 2014 and is based in Dublin, Ireland.

Thrive is a healthcare company focused on saving lives by making earlier detection of cancer a routine part of medical care. It develops CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of the disease. CancerSEEK will serve as the core of Thrive’s integrated cancer information offering. The company was launched in 2019 by Third Rock Ventures, with funding from additional investors Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3.

Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.

908 Devices is bringing the powerful capabilities of Mass Spectrometry out of the confines of centralized facilities and mobile laboratories. The company makes battery-operated, handheld, chemical detection tools, rugged enough to exceed military standards, and trusted enough for immediate action in the field. For biologists and chemists in need of answers, 908 Devices makes personal analyzers, small and simple enough for every workspace.

Zinka Logistics Solutions Private Limited develops and operates an online trucking platform that connects shippers and truckers. Its platform enables truckers to book a load and move at capacity; and shippers of various sizes to have access to the truck at the specific time. Zinka Logistics Solutions Private Limited was formerly known as Blackbuck. The company was founded in 2015 and is based in Bengaluru, India.

Upgrade is a neobank that offers credit to mainstream consumers through cards and personal loans, together with free credit monitoring and education tools that help consumers understand and manage their finances. Upgrade Card provides an innovative credit card that brings the low cost and responsible credit of installment lending to millions of retail locations in the U.S., while Upgrade Account is a mobile banking product offered to mainstream consumers.

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.

Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success.

Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.

RedBud Brands is a brand development studio bringing people, ideas, and capital together to create disruptive new companies with an emphasis on the consumer space. It is an innovative venture platform for launching impactful brands that partners with visionary founders and executives to support and supercharge the creation of transformative, valuable, and sustainable companies. The company focuses primarily on premium, consumer packaged goods sectors with an emphasis on 'better-for-you' products.

Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.

DataRobot delivers AI technology and ROI enablement services to global enterprises competing in today’s intelligence revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models. The company was founded in 2012 and is headquartered in Boston, Massachusetts.

Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

Learn more about #paid’s creator media platform at www.hashtagpaid.com/product

Snyk enables users to detect, fix, and prevent known vulnerabilities in third-party code modules, including Node

Klaviyo, Inc. provides an email marketing software. It offers Klaviyo, an email marketing software that features a best practice emails library, segmentation tools, newsletters, analytics and ROI reports, customer profiles, administration tools, APIs, drip campaigns, abandoned carts, sign up forms and list growth, and others. Klaviyo, Inc. was founded in 2012 and is headquartered in Boston, Massachusetts with an additional office in London, United Kingdom.

DataRobot delivers AI technology and ROI enablement services to global enterprises competing in today’s intelligence revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models. The company was founded in 2012 and is headquartered in Boston, Massachusetts.

DocuSign, Inc. provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals. The company was 2003 and is headquartered in San Francisco, California.

KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Check product streamlines recording, waste reconciliation, and billing for medications used in the operating room. Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked.

MuleSoft makes it easy to connect the world’s applications, data, and devices. They provide a software platform that enables organizations to easily build application networks using APIs. APIs are the digital glue that allows applications to talk to each other and exchange data. Their flexible, unified platform connects nearly any application or system by leveraging APIs to quickly and securely share data, regardless of format or source, in application networks. It was founded in 2006 and is headquartered in San Francisco, California,.

Modernizing Medicine® and its affiliated companies are transforming how healthcare information is created, consumed and utilized in order to increase practice efficiency and improve patient outcomes. Their specialty-specific, data-driven and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals. Their suite of products and services is designed to transform the clinical, financial and operational aspects of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices. They also offer products designed specifically for ambulatory surgery centers.

Uhnder is a start-up developing products for sensing, cognition, and communication for the Internet of Things (IoT) market. It is headquartered in California with engineering and operations based in Austin and St. Louis. Uhnder develops a digital automotive radar-on-chip designed to automate systems for safety and better feedback response. Uhnder disrupts the autonomous vehicle business with what it says is a more accurate and reliable alternative to light detection and ranging, known as lidar, which is one of the most common technologies used to make vehicles more aware of their surroundings. Uhnder's chip helps to avoid collisions, alerts to potential problems, helps with quick localization, as electronic fences for navigation and localization and for communication.

UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

Modernizing Medicine® and its affiliated companies are transforming how healthcare information is created, consumed and utilized in order to increase practice efficiency and improve patient outcomes. Their specialty-specific, data-driven and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals. Their suite of products and services is designed to transform the clinical, financial and operational aspects of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices. They also offer products designed specifically for ambulatory surgery centers.

nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.

PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.

Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.